Dr. Lesley Ann
Ogilvie

Dr. Lesley Ogilvie is a researcher at Alacris Theranostics, a spin off company from the Max Planck Institute for Molecular Genetics, Berlin, focused on innovative solutions for personalised oncology. She has over 10 years of experience working in academia as a researcher and lecturer, applying molecular and bioinformatics techniques to further understand the human gut microbiome in health and disease. She joined Alacris Theranostics in 2014, with the aim of exploring personalised medicine concepts and is currently leading efforts to further research and development opportunities within the company.